Geneos Wealth Management Inc. Acquires 8,021 Shares of Schrödinger, Inc. (NASDAQ:SDGR)

Geneos Wealth Management Inc. grew its holdings in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 15.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 59,996 shares of the company’s stock after buying an additional 8,021 shares during the period. Geneos Wealth Management Inc. owned approximately 0.08% of Schrödinger worth $1,157,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the stock. KBC Group NV boosted its stake in Schrödinger by 45.4% during the third quarter. KBC Group NV now owns 2,508 shares of the company’s stock worth $47,000 after acquiring an additional 783 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Schrödinger by 87.5% in the 4th quarter. GAMMA Investing LLC now owns 2,796 shares of the company’s stock valued at $54,000 after buying an additional 1,305 shares during the period. Quarry LP increased its position in Schrödinger by 1,150.0% in the 3rd quarter. Quarry LP now owns 2,825 shares of the company’s stock valued at $52,000 after buying an additional 2,599 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in Schrödinger during the 3rd quarter worth approximately $102,000. Finally, Point72 DIFC Ltd bought a new position in Schrödinger in the third quarter worth approximately $151,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. BMO Capital Markets upped their target price on Schrödinger from $25.00 to $28.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. KeyCorp raised their price objective on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Friday. Three equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Schrödinger has an average rating of “Moderate Buy” and a consensus target price of $32.11.

Schrödinger Stock Performance

NASDAQ:SDGR opened at $24.07 on Tuesday. Schrödinger, Inc. has a 52 week low of $16.67 and a 52 week high of $33.63. The firm has a 50-day moving average price of $20.82 and a two-hundred day moving average price of $20.09. The firm has a market cap of $1.75 billion, a price-to-earnings ratio of -10.29 and a beta of 1.59.

Schrödinger (NASDAQ:SDGR) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.52) EPS for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The business had revenue of $35.30 million for the quarter, compared to analysts’ expectations of $41.25 million. During the same period in the previous year, the business posted ($0.86) earnings per share. The business’s revenue was down 17.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Schrödinger, Inc. will post -2.29 earnings per share for the current year.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.